Remove Disease Remove Pharmacogenetics Remove Treatment
article thumbnail

Open Targets Platform 23.12 has been released!

The Open Targets Blog

The new page can be accessed from the target-disease associations page when searching for targets associated with a disease, and clicking on the target prioritisation factors tab. Target prioritisation view for Crohn's Disease. Clicking on one of the cells will bring up the data informing the assessment.

article thumbnail

A personal touch: the role of bioprinting in drug discovery

Drug Discovery World

The company hopes that through its technology, academics, life science industries and pharma industries can test and develop more personalised treatments for intricate tissue engineering and cell therapy, such as repairing damaged tissue, replacing lost biological functions, localised therapeutic solutions and complex drug formulations. .

article thumbnail

The use-case for NGS

Drug Discovery World

We can use NGS to better understand so-called “pharmacogenetics” so that we can predict how an individual may respond to a given treatment. Two different people could have the same type of cancer, but their tumour’s genetics could be ever so slightly different, but different enough that the treatment response is completely different.